Engineered mesenchymal stem-cell-sheets patches prevents postoperative pancreatic leakage in a rat model

Sci Rep. 2018 Jan 10;8(1):360. doi: 10.1038/s41598-017-18490-9.

Abstract

Post-operative pancreatic fistula (POPF) following pancreatic resection is a life-threatening surgical complication. Cell sheets were prepared and harvested using temperature-responsive culture dishes and transplanted as patches to seal POPF. Two different mesenchymal stem cell (MSC) sheets were compared in terms of the preventative ability for pancreatic leakage in a rat model. Both rat adipose-derived stem cell (rADSC) and bone marrow-derived stem cell (rBMSC) sheets were transplanted. Those rADSC and rBMSC sheets are created without enzymes and thus maintained their cell-cell junctions and adhesion proteins with intact fibronectin on the basal side, as well as characteristics of MSCs. The rats with post-pancreatectomy rADSC- or rBMSC-sheet patches had significantly decreased abdominal fluid leakage compared with the control group, demonstrated by MR image analysis and measurement of the volume of abdominal fluid. Amylase level was significantly lower in the rats with rADSC-sheet and rBMSC-sheet patches compared with the control groups. The rADSC sheet patches had increased adhesive and immune-cytokine profiles (ICAM-1, L-selectin, TIMP-1), and the rBMSC sheets had reduced immune reactions compared to the control. This is first project looking at the feasibility of tissue engineering therapy using MSC-sheets as tissue patches preventing leakage of abdominal fluid caused by POPF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / metabolism
  • Animals
  • Biomarkers
  • Disease Models, Animal
  • Immunohistochemistry
  • Magnetic Resonance Imaging
  • Mesenchymal Stem Cells* / cytology
  • Pancreatic Fistula / diagnostic imaging
  • Pancreatic Fistula / etiology*
  • Pancreatic Fistula / pathology
  • Pancreatic Fistula / therapy*
  • Postoperative Complications*
  • Rats
  • Rats, Transgenic
  • Tissue Engineering*
  • Treatment Outcome

Substances

  • Biomarkers
  • Amylases